A Case of Severe, Nilotinib-Induced Liver Injury

Idiosyncratic hepatotoxicity is a leading reason for the discontinuation or dose modification of Food and Drug Administration (FDA)-approved medications in the United States. We report the case of a 53-year-old woman with chronic myeloid leukemia who developed acute cholestatic hepatitis in response...

Descripción completa

Detalles Bibliográficos
Autores principales: Belopolsky, Yuliya, Grinblatt, David L., Dunnenberger, Henry M., Sabatini, Linda M., Joseph, Nora E., Fimmel, Claus J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657995/
https://www.ncbi.nlm.nih.gov/pubmed/31616712
http://dx.doi.org/10.14309/crj.0000000000000003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657995/
https://www.ncbi.nlm.nih.gov/pubmed/31616712
http://dx.doi.org/10.14309/crj.0000000000000003

Ejemplares similares